EGFR and non-small cell lung carcinoma: Through the study of the regulation of miR-1299 by MELTF-AS1, combined with the report of Cao and colleagues, it was found that miR-1299 inhibits the progression of NSCLC through the EGFR/PI3K/Akt signaling pathway [32].